Accuray Incorporated (ARAY) Shares are Down -2.57%

Accuray Incorporated (ARAY) : During the past 4 weeks, traders have been relatively bearish on Accuray Incorporated (ARAY), hence the stock is down -1.31% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -2.54% relative to the S&P 500. The 4-week change in the price of the stock is -0.93% and the stock has fallen -2.57% in the past 1 week.

Accuray Incorporated is up 1.34% in the last 3-month period. Year-to-Date the stock performance stands at -21.33%. The stock has recorded a 20-day Moving Average of 2.68% and the 50-Day Moving Average is 0.52%.


Accuray Incorporated (NASDAQ:ARAY): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $5.00 and $5.00 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $5.32. The buying momentum continued till the end and the stock did not give up its gains. It closed at $5.31, notching a gain of 6.20% for the day. The total traded volume was 1,828,913 . The stock had closed at $5.00 on the previous day.

Accuray Incorporated is a radiation oncology company. The Company develops, manufactures, sells and supports treatment solutions. Its suite of products includes the CyberKnife Systems and the TomoTherapy Systems. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy and adaptive radiation therapy. Its principal radiosurgery products, the CyberKnife Systems are robotic full-body radiosurgery system designed to treat tumors anywhere in the body non-invasively, which include the CyberKnife M6 Series with configuration options of fixed collimators plus iris variable aperture collimator, fixed collimators plus the InCise MLC and fixed collimators plus iris variable aperture collimator and the InCise MLC. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.